• The talks given at ISAD 2021 will be provided as an on-demand service on the website for a month with the consent of the speakers.
  • Posting Period : April 27, 2021 – May 26, 2021
 
Monday, April 19th, 2021
Time (KST) Program Speaker Replay
Opening ceremony
14:00 - 14:30
(UTC 05:00 - 05:30)
Welcome address: ISAD 2021 General Chair Kyu-Han Kim
Introduction Susanne Rajka
Welcome address: ISAD President Alain Taieb
Introduction into ISAD and Rajka meetings Johannes Ring
Session 1
14:30 - 16:00
(UTC 05:30 - 07:00)
Diagnostic criteria for adult atopic dermatitis
Lawrence Eichenfield, Jon Hanifin, Alain Taieb
14:30 - 15:30
(UTC 05:30 - 06:30)
How well do existing diagnostic criteria work for adult atopic dermatitis? Anne-Sofie Halling
Epidemiological insights into adult atopic dermatitis? Jonathan Silverberg
Adult onset atopic dermatitis; fact or fancy? Jon Hanifin
Adult atopic dermatitis phenotypes and disease trajectories Katrina Abuabara
15:30 - 15:50
(UTC 06:30 - 06:50)
Diagnostic criteria for Korean adult atopic dermatitis: the READ Seung Chul Lee
Different phenotypes and factors associated with atopic dermatitis in the young adult Singaporean Chinese population: a cross-sectional study Fook Tim Chew
15:50 - 16:00
(UTC 06:50 - 07:00)
Summarizing-Defining adult AD in clinical trial and other studies, and how we might work together as a global research group going forward Lawrence Eichenfield
16:00 - 16:30
(UTC 07:00 - 07:30)
Break
Session 2
16:30 - 18:00
(UTC 07:30 - 09:00)
Primary prevention of atopic dermatitis
Hywel Williams, Jun-Mo Yang
16:30 - 17:00
(UTC 07:30 - 08:00)
Primary prevention of atopic dermatitis. Part I : Primary prevention with prebiotics and probiotics Sebastien Barbarot
17:00 - 18:00
(UTC 08:00 - 09:00)
Atopic dermatitis and primary prevention Part II : Allergen avoidance, exposure and/or skin care: myths and facts Peter Schmid-Grendelmeier
A randomised controlled trial of daily emollient during infancy for preventing eczema – results of the BEEP trial Joanne Chalmers
Effects of moisturizing skin care among first 3 months of life Kaori Yonezawa
18:00 - 19:00
(UTC 09:00 - 10:00)
Music Interlude: From São Paulo to Seoul Jin Joo Doh,
Roberto Takaoka
Session 3
19:00 - 20:30
(UTC 10:00 - 11:30)
Mechanisms of atopic dermatitis
Lisa Beck, Michael Cork
19:00 - 19:30
(UTC 10:00 - 10:30)
Overview of pathogenesis of AD Stephan Weidinger
19:30 - 20:30
(UTC 10:30 - 11:30)
Neuroimmunology of pruritus in atopic dermatitis Martin Steinhoff
IgE-mediated reactivity to autoallergens is associated with severity and a TH2 cytokine signature in atopic dermatitis Arturo Borzutzky (oral pt)
Relationship between atopic dermatitis and fine dust Ju Hee Han (oral pt)
Dynamics and properties of sweat: new insights into atopic dermatitis pathogenesis Hiroyuki Murota (oral pt)
20:30 - 21:00
(UTC 11:30 - 12:00)
Break
Session 4
21:00 - 22:30
(UTC 12:00 - 13:30)
Precision medicine and biomarkers
Emma Guttman-Yassky, Thomas Bieber
21:00 - 21:30
(UTC 12:00 - 12:30)
Building a precision medicine approach in AD Emma Guttman-Yassky
21:30 - 22:30
(UTC 12:30 - 13:30)
Genetic biomarkers in Korean atopic dermatitis Eung Ho Choi
The long and challenging way to precision medicine in atopic dermatitis Thomas Bieber
Tape strip global molecular profiling by RNA-sequencing reveals immune and barrier abnormalities in atopic dermatitis and psoriasis Helen He (oral pt)
Unraveling heterogeneity in pediatric atopic dermatitis: identification of serum biomarker based patient clusters Daphne S. Bakker (oral pt)
Tuesday, April 20th, 2021
Time (KST) Program Speaker Replay
Session 5
14:00 - 15:00
(UTC 05:00 - 06:00)
Conventional treatment
Sandipan Dhar, Seong Jun Seo
14:00 - 15:00
(UTC 05:00 - 06:00)
Conventional treatments of AD in China Jianzhong Zhang
Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients Caroline Olesen (oral pt)
Effectiveness and safety of different strategies for using topical corticosteroids in people with eczema - a cochrane systematic review Stephanie Lax (oral pt)
The prescription patterns of topical medications in Korean atopic dermatitis patients using big data from national health insurance corporation Hyunchang Ko (oral pt)
15:00 - 15:30
(UTC 06:00 - 06:30)
Break and E-poster viewing
Session 6
15:30 - 17:00
(UTC 06:30 - 08:00)
New therapies (biologics)
Chun Wook Park, Norito Katoh
15:30 - 16:00
(UTC 06:30 - 07:00)
Overview of new therapies in AD Andreas Wollenberg
16:00 - 17:00
(UTC 07:00 - 08:00)
Three learnings from a performance review of clinical trials in atopic dermatitis Kim Papp
Pitfalls in clinical trials for AD Lawrence Eichenfield
A 52 weeks retrospective study of dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety of dupilumab in real world practice Jiyoung Ahn (oral pt)
Abrocitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis: key efficacy and safety results from phase 3 trials JADE MONO-1 and JADE MONO-2 Eric Simpson (oral pt)
17:00 - 18:00
(UTC 08:00 - 09:00)
Music Interlude: From São Paulo to Seoul Jin Joo Doh,
Roberto Takaoka
Session 7
18:00 - 19:00
(UTC 09:00 - 10:00)
Promising therapies under trial
Mette Deleuran, Mamadou Ball
18:00 - 18:30
(UTC 09:00 - 09:30)
Promising biologic therapies under trial Eric Simpson
18:30 - 19:00
(UTC 09:30 - 10:00)
Promising therapies under trial other than biologics Kenji Kabashima
19:00 - 19:30
(UTC 10:00 - 10:30)
Break
Session 8
19:30 - 21:30
(UTC 10:30 - 12:30)
Gaps in evidence
Carsten Flohr, Stephan Weidinger
19:30 - 20:00
(UTC 10:30 - 11:00)
The ‘hygiene hypothesis’ is dead. Long live the ‘biodiversity hypothesis’! Carsten Flohr
20:00 - 21:00
(UTC 11:00 - 12:00)
Results from the largest whole genome sequencing study of atopic dermatitis with extensive phenotyping. Sandra Smieszek (oral pt)
Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies Stephan Weidinger (oral pt)
Comparing cutaneous molecular and clinical improvement with different treatments in atopic dermatitis patients Jacob Glickman (oral pt)
21:00 - 21:30
(UTC 12:00 - 12:30)
COVID-19 in AD Carsten Flohr
21:30 - 22:00
(UTC 12:30 - 13:00)
Awards for best posters and oral presentations Kyu-Han Kim
Rajka Medal Awards Alain Taieb, Susanne Rajka
Next ISAD Introduction Danielle Marcoux
Closing remarks Alain Taieb
 
Monday, April 19th, 2021
Time(KST) Program Replay
Opening ceremony
14:00 - 14:30
(UTC 05:00 - 05:30)
Welcome address: ISAD 2021 General Chair
/ Kyu-Han Kim
Introduction
/ Susanne Rajka
Welcome address: ISAD President
/ Alain Taieb
Introduction into ISAD and Rajka meetings
/ Johannes Ring
Session 1
14:30 - 16:00
(UTC 05:30 - 07:00)
Diagnostic criteria for adult atopic dermatitis
/ Lawrence Eichenfield, Jon Hanifin, Alain Taieb
14:30 - 15:30
(UTC 05:30 - 06:30)
How well do existing diagnostic criteria work for adult atopic dermatitis?
/ Anne-Sofie Halling
Epidemiological insights into adult atopic dermatitis?
/ Jonathan Silverberg
Adult onset atopic dermatitis; fact or fancy?
/ Jon Hanifin
Adult atopic dermatitis phenotypes and disease trajectories
/ Katrina Abuabara
15:30 - 15:50
(UTC 06:30 - 06:50)
Diagnostic criteria for Korean adult atopic dermatitis: the READ
/ Seung Chul Lee
Different phenotypes and factors associated with atopic dermatitis in the young adult Singaporean Chinese population: a cross-sectional study
/ Fook Tim Chew
15:50 - 16:00
(UTC 06:50 - 07:00)
Summarizing-Defining adult AD in clinical trial and other studies, and how we might work together as a global research group going forward
/ Lawrence Eichenfield
16:00 - 16:30
(UTC 07:00 - 07:30)
Break
Session 2
16:30 - 18:00
(UTC 07:30 - 09:00)
Primary prevention of atopic dermatitis
/ Hywel Williams, Jun-Mo Yang
16:30 - 17:00
(UTC 07:30 - 08:00)
Primary prevention of atopic dermatitis. Part I : Primary prevention with prebiotics and probiotics
/ Sebastien Barbarot
17:00 - 18:00
(UTC 08:00 - 09:00)
Atopic dermatitis and primary prevention Part II : Allergen avoidance, exposure and/or skin care: myths and facts
/ Peter Schmid-Grendelmeier
A randomised controlled trial of daily emollient during infancy for preventing eczema – results of the BEEP trial
/ Joanne Chalmers
Effects of moisturizing skin care among first 3 months of life
/ Kaori Yonezawa
18:00 - 19:00
(UTC 09:00 - 10:00)
Music Interlude: From São Paulo to Seoul
/ Jin Joo Doh, Roberto Takaoka
Session 3
19:00 - 20:30
(UTC 10:00 - 11:30)
Mechanisms of atopic dermatitis
/ Lisa Beck, Michael Cork
19:00 - 19:30
(UTC 10:00 - 10:30)
Overview of pathogenesis of AD
/ Stephan Weidinger
19:30 - 20:30
(UTC 10:30 - 11:30)
Neuroimmunology of pruritus in atopic dermatitis
/ Martin Steinhoff
IgE-mediated reactivity to autoallergens is associated with severity and a TH2 cytokine signature in atopic dermatitis
/ Arturo Borzutzky (oral pt)
Relationship between atopic dermatitis and fine dust
/ Ju Hee Han (oral pt)
Dynamics and properties of sweat: new insights into atopic dermatitis pathogenesis
/ Hiroyuki Murota (oral pt)
20:30 - 21:00
(UTC 11:30 - 12:00)
Break
Session 4
21:00 - 22:30
(UTC 12:00 - 13:30)
Precision medicine and biomarkers
/ Emma Guttman-Yassky, Thomas Bieber
21:00 - 21:30
(UTC 12:00 - 12:30)
Building a precision medicine approach in AD
/ Emma Guttman-Yassky
21:30 - 22:30
(UTC 12:30 - 13:30)
Genetic biomarkers in Korean atopic dermatitis
/ Eung Ho Choi
The long and challenging way to precision medicine in atopic dermatitis
/ Thomas Bieber
Tape strip global molecular profiling by RNA-sequencing reveals immune and barrier abnormalities in atopic dermatitis and psoriasis
/ Helen He (oral pt)
Unraveling heterogeneity in pediatric atopic dermatitis: identification of serum biomarker based patient clusters
/ Daphne S. Bakker (oral pt)
Tuesday, April 20th, 2021
Time(KST) Program Replay
Session 5
14:00 - 15:00
(UTC 05:00 - 06:00)
Conventional treatment
/ Sandipan Dhar, Seong Jun Seo
14:00 - 15:00
(UTC 05:00 - 06:00)
Conventional treatments of AD in China
/ Jianzhong Zhang
Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients
/ Caroline Olesen (oral pt)
Effectiveness and safety of different strategies for using topical corticosteroids in people with eczema - a cochrane systematic review
/ Stephanie Lax (oral pt)
The prescription patterns of topical medications in Korean atopic dermatitis patients using big data from national health insurance corporation
/ Hyunchang Ko (oral pt)
15:00 - 15:30
(UTC 06:00 - 06:30)
Break and E-poster viewing
Session 6
15:30 - 17:00
(UTC 06:30 - 08:00)
New therapies (biologics)
/ Chun Wook Park, Norito Katoh
15:30 - 16:00
(UTC 06:30 - 07:00)
Overview of new therapies in AD
/ Andreas Wollenberg
16:00 - 17:00
(UTC 07:00 - 08:00)
Three learnings from a performance review of clinical trials in atopic dermatitis
/ Kim Papp
Pitfalls in clinical trials for AD
/ Lawrence Eichenfield
A 52 weeks retrospective study of dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety of dupilumab in real world practice
/ Jiyoung Ahn (oral pt)
Abrocitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis: key efficacy and safety results from phase 3 trials JADE MONO-1 and JADE MONO-2
/ Eric Simpson (oral pt)
17:00 - 18:00
(UTC 08:00 - 09:00)
Music Interlude: From São Paulo to Seoul
/ Jin Joo Doh, Roberto Takaoka
Session 7
18:00 - 19:00
(UTC 09:00 - 10:00)
Promising therapies under trial
/ Mette Deleuran, Mamadou Ball
18:00 - 18:30
(UTC 09:00 - 09:30)
Promising biologic therapies under trial
/ Eric Simpson
18:30 - 19:00
(UTC 09:30 - 10:00)
Promising therapies under trial other than biologics
/ Kenji Kabashima
19:00 - 19:30
(UTC 10:00 - 10:30)
Break
Session 8
19:30 - 21:30
(UTC 10:30 - 12:30)
Gaps in evidence
/ Carsten Flohr, Stephan Weidinger
19:30 - 20:00
(UTC 10:30 - 11:00)
The ‘hygiene hypothesis’ is dead. Long live the ‘biodiversity hypothesis’!
/ Carsten Flohr
20:00 - 21:00
(UTC 11:00 - 12:00)
Results from the largest whole genome sequencing study of atopic dermatitis with extensive phenotyping.
/ Sandra Smieszek (oral pt)
Treat-to-target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies
/ Stephan Weidinger (oral pt)
Comparing cutaneous molecular and clinical improvement with different treatments in atopic dermatitis patients
/ Jacob Glickman (oral pt)
21:00 - 21:30
(UTC 12:00 - 12:30)
COVID-19 in AD
/ Carsten Flohr
21:30 - 22:00
(UTC 12:30 - 13:00)
Awards for best posters and oral presentations
/ Kyu-Han Kim
Rajka Medal Awards
/ Alain Taieb, Susanne Rajka
Next ISAD Introduction
/ Danielle Marcoux
Closing remarks
/ Alain Taieb